FindMyRecallSubscribe
Class I: serious health riskTerminated

Mobius Therapeutics Mitosol Recall

Mitosol (mitomycin for solution), 0

Mobius Therapeutics LLC · Saint Louis, MO

Risk level
Class I
Reported by FDA
Jul 31, 2013
Recall ID
D-809-2013
Check your lot numberHow we source this data

Summary

Mobius Therapeutics recalled Mitosol starting Jan 3, 2013. The FDA classified it as Class I (serious health risk) and published enforcement report D-809-2013 on Jul 31, 2013. Reason: Non-Sterility: one or more components of the kit have been found to be contaminated with yeast. Status: Terminated.

Why it was recalled

Non-Sterility: one or more components of the kit have been found to be contaminated with yeast.

Product description

Mitosol (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic Use (NDC 49771-002-01), 3 kits per box (NDC 49771-002-03), Rx only, Manufactured for: Mobius Therapeutics, LLC, 4041 Forest Park Avenue, St. Louis, MO 63108 USA.

Lot numbers, UPCs & expiration codes

Lot #: M086920 and M098260, Exp. 08/2013

Where it was sold

Nationwide and Military and Government Consignees

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-809-2013
Classification
Class I
Status
Terminated
Recall initiated
Jan 3, 2013
FDA report date
Jul 31, 2013
Quantity
83 boxes
Recall type
Voluntary: Firm initiated
Recalling firm
Mobius Therapeutics LLC

Original FDA data

Every field from FDA enforcement report D-809-2013, exactly as published.

Show all FDA fields
City
Saint Louis
State
MO
Status
Terminated
Country
United States
Event ID
64018
Address
4041 Forest Park Ave
Code information
Lot #: M086920 and M098260, Exp. 08/2013
Postal code
63108-3213
Report date
Jul 31, 2013
Product type
Drugs
Recall number
D-809-2013
Classification
Class I
Recalling firm
Mobius Therapeutics LLC
Product quantity
83 boxes
Termination date
Jul 29, 2013
Reason for recall
Non-Sterility: one or more components of the kit have been found to be contaminated with yeast.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Mitosol (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic Use (NDC 49771-002-01), 3 kits per box (NDC 49771-002-03), Rx only, Manufactured for: Mobius Therapeutics, LLC, 4041 Forest Park Avenue, St. Louis, MO 63108 USA.
Distribution pattern
Nationwide and Military and Government Consignees
Recall initiation date
Jan 3, 2013
Initial firm notification
Telephone
Center classification date
Jul 19, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-809-2013, published Jul 31, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls